StopDown
Funding · 8 June 2026WholeleafRs 5 croreNatural pain therapeutics company

Wholeleaf in advanced talks to raise Rs 7.5 crore

By · Editor ·

seedFounded 2021
  • Wholeleaf makes medically oriented natural pain therapeutics for chronic and neuropathic pain
  • It is in advanced talks to raise Rs 7.5 crore from IPV and Benzai 10 Capital
  • The company has an annual recurring revenue of Rs 18 crore and nearly 2,000 retail outlets

What happened

  • Wholeleaf is in advanced talks to raise Rs 7.5 crore from IPV and Benzai 10 Capital.
  • The company makes medically oriented natural pain therapeutics.
  • It focuses on chronic and neuropathic pain management.
  • Wholeleaf leads the cannabinoid pain therapeutics category in India.
  • Its portfolio includes oral tinctures and topical formulations for migraines, arthritis, fibromyalgia, menstrual pain, anxiety, and sleeplessness.
  • The company has a pipeline for chronic neuropathic pain solutions.
  • It has raised Rs 5 crore to date, including a seed round of Rs 1.5 crore from Shark Tank India investors and Rs 3.5 crore from ah! Ventures and angels.

Why it matters

  • It will also scale distribution and enhance brand visibility both online and offline.
  • The company plans to expand from nearly 2,000 retail outlets to 5,000–7,000 this year.
  • Target cities for deeper penetration include Bengaluru, Mumbai, Hyderabad, Kolkata, Ahmedabad, Goa, and Chennai.

The business

  • Wholeleaf is a medically oriented natural pain therapeutics company launched in 2021.
  • It focuses on chronic and neuropathic pain management.
  • The company leads the cannabinoid pain therapeutics category in India.
  • Its product portfolio includes oral tinctures and topical formulations for migraines, arthritis, fibromyalgia, menstrual pain, anxiety, and sleeplessness.
  • Wholeleaf has a pipeline for chronic neuropathic pain solutions.
  • Product development is physician-led with multi-stage validation including safety testing, pilot studies, and third-party government-certified lab assessments.
  • The company has nearly 2,000 retail outlets, primarily in Delhi-NCR.
  • It has an annual recurring revenue of Rs 18 crore.

The founders

Shivraj Sharma

Founder and CEO
  • Shivraj Sharma is the founder and CEO of Wholeleaf.

Who put in money

  • IPV participated — IPV is an institutional investor participating in this round.
  • Benzai 10 Capital participated — Benzai 10 Capital is an institutional investor participating in this round.

In numbers

Rs 7.5 croreAnnual Recurring Revenue
nearly 2,000Retail outlets
Rs 5 croreTotal raised to date

What happens next

  • Wholeleaf plans to use the funds to accelerate offline retail expansion, strengthen product development, scale distribution, and enhance brand visibility online and offline.
  • It aims to expand from nearly 2,000 retail outlets to 5,000–7,000 this year.
  • Target cities for deeper penetration include Bengaluru, Mumbai, Hyderabad, Kolkata, Ahmedabad, Goa, and Chennai.

Earlier rounds

  • seed · Rs 1.5 crore · led by Shark Tank India investors
  • Rs 3.5 crore · led by ah! Ventures and angels

Words to know

cannabinoid pain therapeutics
Pain relief products that use compounds derived from cannabis plants, such as CBD, to manage pain without the psychoactive effects of THC.
neuropathic pain
Pain caused by damage or disease affecting the nervous system, often described as shooting, burning, or tingling.
ARR
Annual Recurring Revenue, a metric that shows the predictable revenue a company expects to receive every year from its customers.
tinctures
Liquid extracts made by soaking herbs or plant materials in alcohol or another solvent, taken orally for therapeutic effects.

The numbers around it

Wholeleaf has 2 funding rounds in StopDown's archive.

#The numbers around it
WhenRoundAmountLed by
26 February 2026SeedRs 1.5 croreAman Gupta

Healthcare & Life Sciences in June 2026: 11 rounds with a disclosed amount, $118 million in all; the biggest was Vetic ($40 Mn). Every sector this year →

Read it as a card in the app

Terms in this story

  • ARR and MRR: MRR is the monthly recurring revenue a company expects from subscriptions, and ARR is that figure times twelve. They suit software and subscription companies only. ARR is a run rate, not booked revenue, so ARR claims in Indian news can differ from filed accounts.

Everything on Wholeleaf → · All startup news on 8 June 2026 →

Is this Wholeleaf? Get your “Featured on StopDown” badge →